Clinical Research Directory

Inclusion Criteria: 1. Provision of signed and dated informed consent form. 2. Presence of self-reported hearing or mobility disability. 3. Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study. 4. Males and females; Age 22 and above. 5. Score of 10 or greater on the Patient Health Questionnaire-9 (PHQ-9) or Generalized Anxiety Disorder-7 (GAD-7) (to be assessed post-study-specific screening consent). 6. Willingness to adhere to the study regiment. 7. Access to necessary resources for participating in a technology-based intervention (i.e., iPhone, internet access). 8. Treatment stability (no changes in psychotropic medication or psychotherapy treatment in the 30 days before study entry). 9. Able to read and speak English fluently. 10. Resident of the US and living in the US for the duration of the trial. - Exclusion Criteria: 1. Medical diagnosis of psychotic disorder or bipolar disorder. 2. Participation in another treatment trial at the time of study. 3. Substance use disorder. In the past 12 months (not including tobacco). 4. Suicide attempt in the past year or elevated suicide risk other than passive ideation (i.e., endorsing items reflecting intent, identifying means, suicide planning, or suicide-related preparations). 5. Currently pregnant or planning to become pregnant during the treatment period. -